106 related articles for article (PubMed ID: 3326593)
21. [The role of major histocompatibility complex genes in the pathogenesis of chronic inflammatory bowel diseases].
Matri S; Boubaker J; Hamzaoui S; Bardi R; Ayed K; Filali A
Tunis Med; 2003 May; 81(5):289-94. PubMed ID: 12934447
[TBL] [Abstract][Full Text] [Related]
22. [Construction of mutants of MHC class II molecule transactivator gene capable of suppressing HLA-DR/DQ expression and exploration on their mechanism].
Ou QS; Lin L; Huang LD; Lu PH; Zhou GY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):417-20. PubMed ID: 15169643
[TBL] [Abstract][Full Text] [Related]
23. Increased HLA-DR antigen expression in human hepatocytes after liver transplantation: kinetic analysis using fine needle aspiration biopsy.
Zannier A; Faure JL; Mutin M; Marceau M; Brochier J; Revillard JP
Transplant Proc; 1988 Apr; 20(2):202-4. PubMed ID: 3284041
[No Abstract] [Full Text] [Related]
24. Nomenclature for factors of the HLA System, update December 2000.
Marsh SG
Eur J Immunogenet; 2001 Apr; 28(2):191-3. PubMed ID: 11284989
[No Abstract] [Full Text] [Related]
25. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
26. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
[TBL] [Abstract][Full Text] [Related]
27. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
28. Monitoring after transplantation in liver and kidney transplant recipients with anti-donor HLA antibodies.
Torlone N; Piazza A; Valeri M; Tisone G; Poggi E; Provenzani L; Monaco PI; Adorno D; Casciani CU
Transplant Proc; 1993 Dec; 25(6):3275-6. PubMed ID: 8266540
[No Abstract] [Full Text] [Related]
29. [Characteristics of HLA II antigen expression in the rectal mucosa of children suffering form ulcerative colitis and Crohn disease].
Hacsek G; Arató A; Savilahti E; Pászti I
Orv Hetil; 1995 Oct; 136(42):2279-82. PubMed ID: 7478471
[TBL] [Abstract][Full Text] [Related]
30. The role of immunological parameters in kidney transplantation.
Kreisler JM
Proc Eur Dial Transplant Assoc; 1983; 19():407-23. PubMed ID: 6348742
[No Abstract] [Full Text] [Related]
31. HLA, anthropology, and transplantation.
Parham P
Transplant Proc; 1993 Feb; 25(1 Pt 1):159-61. PubMed ID: 8438260
[No Abstract] [Full Text] [Related]
32. [The major histocompatibility complex in man: a molecular approach].
Giphart MJ
Ned Tijdschr Geneeskd; 1982 Jan; 126(4):154-61. PubMed ID: 6173776
[No Abstract] [Full Text] [Related]
33. Major histocompatibility complex.
Goust JM
Immunol Ser; 1993; 58():29-48. PubMed ID: 8424978
[No Abstract] [Full Text] [Related]
34. Evidence for a specific post-transcriptional mechanism controlling the expression of HLA-DQ, but not -DR and -DP, molecules.
De Lerma Barbaro A; Sartoris S; Tosi G; Nicolis M; Accolla RS
J Immunol; 1994 Nov; 153(10):4530-8. PubMed ID: 7525708
[TBL] [Abstract][Full Text] [Related]
35. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
Sieders E; Hepkema BG; Peeters PM; TenVergert EM; de Jong KP; Porte RJ; Bijleveld CM; van den Berg AP; Lems SP; Gouw AS; Slooff MJ
Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
[TBL] [Abstract][Full Text] [Related]
36. DR, DQ, and you: MHC alleles and autoimmunity.
Sønderstrup G; McDevitt HO
J Clin Invest; 2001 Apr; 107(7):795-6. PubMed ID: 11285296
[No Abstract] [Full Text] [Related]
37. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
38. HLA-A, B, DR, and DQ antigens in black patients with idiopathic dilated cardiomyopathy.
Maharaj B; Hammond MG
Am J Cardiol; 1990 Jun; 65(20):1402-3. PubMed ID: 2343829
[No Abstract] [Full Text] [Related]
39. The HLA system. Second of two parts.
Klein J; Sato A
N Engl J Med; 2000 Sep; 343(11):782-6. PubMed ID: 10984567
[No Abstract] [Full Text] [Related]
40. MHC expression on human hepatocytes before and after isolation.
Burke EC; Martinez OM; Freise CE; McVicar J; Roberts JP; Ascher NL
Transplant Proc; 1991 Feb; 23(1 Pt 2):1428-9. PubMed ID: 1989254
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
